Company Rapid Micro Biosystems, Inc.

Equities

RPID

US75340L1044

Pharmaceuticals

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.9456 USD -0.46% Intraday chart for Rapid Micro Biosystems, Inc. +6.25% +27.78%

Business Summary

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Number of employees: 193

Sales per Business

USD in Million2022Weight2023Weight Delta
Growth Direct Systems, Proprietary Consumables, Laboratory Information Management System Connection Software and Services
65.7 %
11 64.5 % 15 65.7 % +33.91%
Service
34.3 %
6 35.5 % 8 34.3 % +26.94%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
43.9 %
9 51.2 % 10 43.9 % +12.68%
Switzerland
17.7 %
3 16.1 % 4 17.7 % +44.96%
All Other Countries
17.6 %
3 17.3 % 4 17.6 % +33.98%
Japan
11.4 %
-- 3 11.4 % -
Germany
9.4 %
3 15.5 % 2 9.4 % -20.12%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 14-09-30
Director of Finance/CFO 54 18-09-30
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 56 21-01-11
Director/Board Member 54 09-06-30
Investor Relations Contact - 22-01-19
Sales & Marketing - 23-05-03
General Counsel 49 21-04-30
Human Resources Officer 56 20-08-31

Members of the board

Members of the board TitleAgeSince
Chairman 58 23-07-13
Director/Board Member 75 16-03-14
Director/Board Member 54 09-06-30
Director/Board Member 53 13-05-31
Chief Executive Officer 55 14-09-30
Director/Board Member 45 18-03-31
Director/Board Member 66 21-05-31
Director/Board Member 51 21-12-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 5,309,529 0 0 75.47 %
Stock B 1 37,483,559 32,297,426 ( 86.16 %) 0

Shareholders

NameEquities%Valuation
Bain Capital Life Sciences LP
22.68 %
8,434,560 22.68 % 8 M $
Kennedy Lewis Management LP
13.28 %
4,939,931 13.28 % 5 M $
Longitude Capital Management Co LLC
9.568 %
3,557,952 9.568 % 3 M $
Endeavour Vision SA
6.069 %
2,257,099 6.069 % 2 M $
Colony Harvest Ltd.
4.362 %
1,622,260 4.362 % 2 M $
Glenview Capital Management LLC
3.545 %
1,318,288 3.545 % 1 M $
Ally Bridge Group HK Ltd
2.792 %
1,038,296 2.792 % 1 M $
BlackRock Advisors LLC
2.693 %
1,001,607 2.693 % 971 559 $
JPMorgan Securities LLC
2.017 %
750,036 2.017 % 727 535 $
Vanguard Group, Inc. (Subfiler)
1.959 %
728,374 1.959 % 706 523 $

Company contact information

Rapid Micro Biosystems, Inc.

1001 Pawtucket Boulevard West Suite 280

01854, Lowell

+

http://www.rapidmicrobio.com
address Rapid Micro Biosystems, Inc.(RPID)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.9456 USD
Average target price
5.25 USD
Spread / Average Target
+455.20%
Consensus
  1. Stock Market
  2. Equities
  3. RPID Stock
  4. Company Rapid Micro Biosystems, Inc.